Additionally, NLRP3 deficiency led to a decrease in the amyloid-β levels and deposition suggesting an aggravating role of the NLRP3 inflammasome in the pathology of Alzheimer’s disease (Heneka et al. 2013). The gene discussed is NLRP3; the disease is early-onset autosomal dominant Alzheimer disease.